Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery

Journal of Evaluation in Clinical Practice

Volumn 14, Issue 4, 2008, Pages 585-594

  Gerkens, Sophie ^a   Beguin, Claire ^b   Crott, Ralph ^b   Closon, Marie Christine ^a   Horsmans, Yves ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Administrative databases; Health economics; Low molecular weight heparin; Major orthopaedic surgery; Quality of care

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; DEXTRAN; ENOXAPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BODY WEIGHT; BRAIN HEMORRHAGE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DRUG MEGADOSE; DRUG SCREENING; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEMATURIA; HIP FRACTURE; HIP SURGERY; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; INFORMATION SYSTEM; INTRAOCULAR HEMORRHAGE; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORTHOPEDIC SURGERY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; CLINICAL PROTOCOLS; FEMALE; GUIDELINE ADHERENCE; HEALTH EXPENDITURES; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HIP FRACTURES; HOSPITALS, UNIVERSITY; HUMANS; INFORMATION SYSTEMS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 64549085413     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2007.00926.x     Document Type: Article

References (29)

1. Healey, M. & Deverka, P. (1999) Panel 1: methodological issues in pharmacoeconomic evaluations - clinical studies. Value in Health, 2 (2), 73-77.
2. Arnold, R. G. & Kotsanos, J. G. (1999) Panel 3: methodological issues in conducting pharmacoeconomic evaluations - retrospective and claims database studies. Value in Health, 2 (2), 82-87.
3. Hay, J. (1999) Health care costs and outcomes: how should we evaluate real world data? Value in Health, 2 (6), 417-419.
4. Iezzoni, L. I. (1997) Assessing quality using administrative data. Annals of International Medicine, 127 (8 Part 2), 666-674.
5. Vincent, C., Davy, C., Esmail, A., Neale, G., Elstein, M., Cozens, J. F. & Walshe, K. (2006) Learning from litigation. The role of claims analysis in patient safety. Journal of Evaluation in Clinical Practice, 12 (6), 665-674.
6. Blumenthal, D. (1996) Part 1: quality of care - what is it? New England Journal of Medicine, 335 (12), 891-894.
7. Turpie, A. G., Bauer, K. A., Eriksson, B. I. & Lassen, M. R. (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Archives of International Medicine, 162 (16), 1833-1840.
8. Annemans, L., Minjoulat-Rey, M. C., De Knock, M., Vranckx, K., Czarka, M., Gabriel, S. & Haentjens, P. (2004) Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium. Acta Clinica Belgica, 59 (6), 346-357.
9. Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W. & Ray, J. G. (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic therapy. Chest, 126 (3 Suppl.), 338S-400S.
10. Colwell, C. W., Collis, D. K., Paulson, R., McCutchen, J. W., Bigler, G. T., Lutz, S. & Hardwick, M. E. (1999) Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. Journal of Bone and Joint Surgery. American Volume, 81 (7), 932-940.
11. Haentjens, P. (1996) Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (nadroparin calcium). Injury, 27 (6), 385-390.
12. Tran, A. H. & Lee, G. (2003) Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery. Annals of Pharmacotherapy, 37 (11), 1632-1643.
13. Kearon, C. (2003) Duration of venous thromboembolism prophylaxis after surgery. Chest, 124 (6 Suppl.), 386S-392S.
14. Comité d'évaluation des pratiques médicales en matière de médicaments. (2002) L'usage Adéquat de L'héparine Non Fractionnée, Des Héparines de Bas Poids Moléculaire et DesAnticoagulants Oraux Dans la Prévention et le Traitement de la Maladie Thrombo-Embolique Veineuse. Brussels: Institut national d'assurance maladie-invalidité.
15. Hainaut, P. (2003) Epidémiologie et pathogénie de la maladie thromboembolique veineuse. Vaisseaux, Coeur, Poumons, 8 (4), 147-151.
16. Thromboembolic Risk Factors (THRIFT) Consensus Group. (1992) Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ, 305 (6853), 567-574.
17. Caffo, B. S. & Booth, J. G. (2003) Monte carlo conditional inference for log-linear and logistic models: a survey of current methodology. Statistical Methods in Medical Research, 12 (2), 109-123.
18. Corcoran, C., Mehta, C., Patel, N. & Senchaudhuri, P. (2001) Computational tools for exact conditional logistic regression. Statistics in Medicine, 20 (17-18), 2723-2739.
19. Bauer, K. A., Eriksson, B. I., Lassen, M. R. & Turpie, A. G. (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. New England Journal of Medicine, 345 (18), 1305-1310.
20. Eriksson, B. I., Bauer, K. A., Lassen, M. R. & Turpie, A. G. (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. New England Journal of Medicine, 345 (18), 1298-1304.
21. Lassen, M. R., Bauer, K. A., Eriksson, B. I. & Turpie, A. G. (2002) Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet, 359 (9319), 1715-1720.
22. Turpie, A. G., Bauer, K. A., Eriksson, B. I. & Lassen, M. R. (2002) Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet, 359 (9319), 1721- 1726.
23. Oster, G., Ollendorf, D. A., Vera-Llonch, M., Hagiwara, M., Berger, A. & Edelsberg, J. (2004) Economic consequences of venous thromboembolism following major orthopedic surgery. Annals of Pharmacotherapy, 38 (3), 377-382.
24. White, R. H., Romano, P. S., Zhou, H., Rodrigo, J. & Bargar, W. (1998) Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Archives of International Medicine, 158 (14), 1525-1531.
25. White, R. H., Zhou, H. & Romano, P. S. (2003) Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thrombosis and Haemostasis, 90 (3), 446-455.
26. Bates, D. W. & Gawande, A. A. (2003) Improving safety with information technology. New England Journal of Medicine, 348 (25), 2526-2534.
27. Durieux, P., Nizard, R., Ravaud, P., Mounier, N. & Lepage, E. (2000) A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA: the Journal of the American Medical Association, 283 (21), 2816-2821.
28. Hunt, D. L., Haynes, R. B., Hanna, S. E. & Smith, K. (1998) Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA: the Journal of the American Medical Association, 280 (15), 1339- 1346.
29. Kucher, N., Koo, S., Quiroz, R., Cooper, J. M., Paterno, M. D., Soukonnikov, B. & Goldhaber, S. Z. (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. New England Journal of Medicine, 352 (10), 969-977.